Fabry disease Trials in Salford, United Kingdom
Conditions / Fabry disease / Salford, United Kingdom
Fabry disease is a medical condition with active clinical research programs worldwide.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00925301 | Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease | COMPLETED | PHASE3 |
| NCT01218659 | Study to Compare the Efficacy and Safety of Oral AT1001 and Enzyme Replacement Therapy in Patients With Fabry Disease | COMPLETED | PHASE3 |
| NCT02795676 | Study of the Safety and Efficacy of PRX-102 Compared to Agalsidase Beta on Renal Function | COMPLETED | PHASE3 |
| NCT06663358 | A Multi-Country Observational Study of Safety and Effectiveness of Elfabrio® in Fabry Patients | RECRUITING | — |
| NCT05206773 | A Study to Evaluate the Effect of Venglustat Tablets on Neuropathic and Abdominal Pain in Male and Female Participants ≥16 Years of Age With Fabry Disease | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03566017 | Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease | COMPLETED | PHASE3 |
| NCT00196742 | Fabry Disease Registry & Pregnancy Sub-registry | RECRUITING | — |
| NCT04040049 | A Fabry Disease Gene Therapy Study | TERMINATED | PHASE1/PHASE2 |
| NCT01458119 | Open-Label Phase 3 Long-Term Safety Study of Migalastat | TERMINATED | PHASE3 |
| NCT03425539 | Efficacy and Safety of Lucerastat Oral Monotherapy in Adult Subjects With Fabry Disease | COMPLETED | PHASE3 |